Clinical Trial Update: SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SGM-101 tumor-targeted fluorescence endoscopy in rectal polyps with suspected T1 adenocarcinoma or high-grade dysplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• SGM-101

Snippet

Sponsor: Leiden University Medical Center | Conditions: Colorectal Cancer, Image | Phase 2 | Status: UNKNOWN